William E. Duke - Sep 1, 2021 Form 4 Insider Report for Kaleido Biosciences, Inc. (KLDO)

Role
Chief Financial Officer
Signature
/s/ William Duke, Jr.
Stock symbol
KLDO
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 04:16 PM
Next filing
Jan 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +60K $0.00 60K Sep 1, 2021 Common Stock 60K $6.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.